Einar Bjornsson

Summary

Country: Sweden

Publications

  1. ncbi Outcome and prognostic markers in severe drug-induced liver disease
    Einar Bjornsson
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    Hepatology 42:481-9. 2005
  2. ncbi Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Liver Int 30:251-8. 2010
  3. ncbi Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    BMC Gastroenterol 8:46. 2008
  4. ncbi Clinical characteristics and prognostic markers in disulfiram-induced liver injury
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    J Hepatol 44:791-7. 2006
  5. ncbi Long-term follow-up of patients with acute liver failure of indeterminate aetiology
    Gu Wei
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 43:984-91. 2008
  6. ncbi Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Liver Int 27:1194-201. 2007
  7. ncbi Health-related quality of life in patients with different stages of liver disease induced by hepatitis C
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 44:878-87. 2009
  8. ncbi The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome
    Riadh Sadik
    Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg 41345, Sweden
    Eur J Gastroenterol Hepatol 22:102-8. 2010
  9. ncbi Drug-induced autoimmune hepatitis: clinical characteristics and prognosis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland
    Hepatology 51:2040-8. 2010
  10. ncbi Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis
    Evangelos Kalaitzakis
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Clin Gastroenterol Hepatol 7:346-52. 2009

Collaborators

Detail Information

Publications31

  1. ncbi Outcome and prognostic markers in severe drug-induced liver disease
    Einar Bjornsson
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    Hepatology 42:481-9. 2005
    ..In conclusion, hepatocellular jaundice has a high but variable mortality rate, depending on the drug involved. The AST and bilirubin levels are the most important predictors of death or liver transplantation...
  2. ncbi Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Liver Int 30:251-8. 2010
    ..Fatigue was recently suggested to predict an increased risk of mortality in a primary biliary cirrhosis (PBC) cohort during follow-up...
  3. ncbi Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    BMC Gastroenterol 8:46. 2008
    ..We aimed to determine the impact of cirrhosis etiology on hepatic encephalopathy and whether hepatic encephalopathy affects health-related QoL among patients with cirrhosis of different etiologies...
  4. ncbi Clinical characteristics and prognostic markers in disulfiram-induced liver injury
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    J Hepatol 44:791-7. 2006
    ..Limited systematic data exists on the incidence of drug-induced hepatotoxicity due to disulfiram and the most important prognostic markers. We aimed to determine the nature and frequency of suspected disulfiram hepatotoxicity in Sweden...
  5. ncbi Long-term follow-up of patients with acute liver failure of indeterminate aetiology
    Gu Wei
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 43:984-91. 2008
    ....
  6. ncbi Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Liver Int 27:1194-201. 2007
    ..Our aim was to investigate the effects of malnutrition and diabetes mellitus on HE in unselected patients with liver cirrhosis...
  7. ncbi Health-related quality of life in patients with different stages of liver disease induced by hepatitis C
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 44:878-87. 2009
    ..The aim of this study was to determine HRQoL in patients in different stages of hepatitis C virus (HCV) and to compare HRQoL in HCV cirrhosis with non-HCV-induced cirrhosis...
  8. ncbi The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome
    Riadh Sadik
    Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg 41345, Sweden
    Eur J Gastroenterol Hepatol 22:102-8. 2010
    ..The aim of this prospective study was to characterize the relationships between symptoms in IBS, GI transit, as a measure of GI motility, and BMI...
  9. ncbi Drug-induced autoimmune hepatitis: clinical characteristics and prognosis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland
    Hepatology 51:2040-8. 2010
    ..These two groups have similar clinical and histological patterns. However, DIAIH patients do not seem to require long-term immunosuppressive therapy...
  10. ncbi Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis
    Evangelos Kalaitzakis
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Clin Gastroenterol Hepatol 7:346-52. 2009
    ....
  11. ncbi The natural history of drug-induced liver injury
    Einar Bjornsson
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Semin Liver Dis 29:357-63. 2009
    ..Recent studies have shown that DILI can infrequently evolve into chronic liver injury including cirrhosis and even liver-related morbidity and mortality in a minority of patients...
  12. ncbi Inadequate use of proton-pump inhibitors in patients with liver cirrhosis
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Eur J Gastroenterol Hepatol 20:512-8. 2008
    ..Patients with liver cirrhosis have a high prevalence of gastrointestinal symptoms. The use of antiacid therapy (AAT) in these patients is unexplored. We aimed to assess the use of AAT in cirrhotic patients...
  13. ncbi Coronary artery disease in patients with liver cirrhosis
    Evangelos Kalaitzakis
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden
    Dig Dis Sci 55:467-75. 2010
    ..We aimed to determine the prevalence and predictive factors of CAD in a cohort of consecutive patients with cirrhosis of various etiologies compared to the general population...
  14. ncbi Small-duct primary sclerosing cholangitis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Med Pol II, SE 413 45 Gothenburg, Sweden
    Curr Gastroenterol Rep 11:37-41. 2009
    ..Recurrence of small-duct PSC after liver transplantation has been reported. Cholangiocarcinoma, the most feared complication of PSC, has not been described in a patient with small-duct PSC without progression first to large-duct PSC...
  15. ncbi The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    J Hepatol 50:511-7. 2009
    ..Chronic evolution after drug-induced liver injury (DILI) has been reported. How often this leads to liver-related morbidity and mortality is unexplored...
  16. ncbi Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial
    Anna Niklasson
    Department of Internal Medicine, Section of Gastroenterology, Sahlgrenska University Hospital, Richertsgatan 18, Göteborg 412 60, Sweden
    Am J Gastroenterol 105:1531-7. 2010
    ..Conflicting data exist on whether discontinuation of proton pump inhibitors (PPIs) is associated with rebound secretion of gastric acid...
  17. ncbi Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis
    Matthias Neuhauser
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Am J Gastroenterol 105:345-53. 2010
    ..Furthermore, we sought to compare the outcome in PBC patients with and without the features of AIH overlap...
  18. ncbi Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure
    Evangelos Kalaitzakis
    Department of Internal Medicine, Faculty of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Am J Clin Nutr 85:808-15. 2007
    ..Liver cirrhosis is associated with reduced energy intake and increased resting energy expenditure...
  19. ncbi The natural history of small-duct primary sclerosing cholangitis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Gastroenterology 134:975-80. 2008
    ..We aimed at determining the natural history and long-term outcomes of a large number of patients with small-duct PSC...
  20. ncbi Role of gastric sensorimotor dysfunction in gastrointestinal symptoms and energy intake in liver cirrhosis
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 42:237-46. 2007
    ..The aim of this study was to investigate gastric accommodation to a meal and sensitivity to gastric distension with reference to energy intake, nutritional status and gastrointestinal symptoms in liver cirrhosis...
  21. ncbi Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy
    Einar Bjornsson
    Division of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Am J Ther 18:198-205. 2011
    ..Most patients had a good biochemical response to steroids, but adverse effects were common. Future work should be directed at finding therapy that is more effective, better tolerated, and of more lasting benefit...
  22. ncbi Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease
    Anna Niklasson
    Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Eur J Gastroenterol Hepatol 20:335-41. 2008
    ....
  23. ncbi Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes
    Steingerdur Anna Gunnarsdottir
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 44:984-93. 2009
    ..The incidence and mortality of liver cirrhosis in Iceland has been reported to be the lowest in the Western world. There are very few data on aetiology, incidence and prognosis among cirrhotics in Sweden...
  24. ncbi Renal function and cognitive impairment in patients with liver cirrhosis
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 42:1238-44. 2007
    ..Renal function has been shown to be important for ammonia metabolism in cirrhosis. Although renal dysfunction is common in cirrhotic patients, its effect on cognitive function is largely unexplored...
  25. ncbi Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, The National University Hospital, Reykjavik, Iceland
    J Hepatol 56:374-80. 2012
    ..Limited data exist on drug-induced liver injury (DILI) associated with statins...
  26. ncbi Abstinence in patients with alcoholic liver cirrhosis: A follow-up study
    Evangelos Kalaitzakis
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Hepatol Res 38:869-76. 2008
    ..Cirrhosis severity (expressed as the MELD) and alcohol abuse treatment during follow up were related to short-term mortality...
  27. ncbi A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)
    Evangelos Kalaitzakis
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital Gothenburg, Sweden
    Ther Clin Risk Manag 3:653-63. 2007
    ....
  28. ncbi Fate of patients with obstructive jaundice
    Einar Bjornsson
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    J Hosp Med 3:117-23. 2008
    ..Systematic data are limited on the etiology and prognosis of unselected patients with obstructive jaundice (OJ). We aimed to review the clinical features, etiology, and prognosis of patients with OJ...
  29. ncbi Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 41:1464-72. 2006
    ..Our aim was to prospectively evaluate gastrointestinal symptoms, malnutrition, and QoL in patients with cirrhosis...
  30. ncbi Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 40:1095-101. 2005
    ..The aim of this study was to determine the nature and number of suspected adverse drug-induced liver disease associated with fatalities and/or liver transplantation since reporting of adverse drug reactions (ADRs) started in Sweden...
  31. ncbi Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, SE 413 45 Gothenburg, Sweden
    Scand J Gastroenterol 40:206-16. 2005
    ..Data are limited on the impact of structured management of the alcohol problem on the risk of recidivism following transplantation in ALD...